Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin

被引：3
|
作者：
Koretz, Ronald L. [1 ]
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 06期
关键词：
ORAL ANTICOAGULANTS; METAANALYSIS;
D O I：
10.7326/ACPJC-2015-163-6-013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] GI bleeding risk with dabigatran and rivaroxaban vs warfarin
    Reactions Weekly, 2015, 1550 (1) : 8 - 8
  • [2] Increased GI Bleeding After Switch from Warfarin to Dabigatran
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2015, 91 (09) : 648 - 648
  • [3] Dabigatran Compared With Rivaroxaban vs Warfarin
    Schwartz, Janice B.
    JAMA INTERNAL MEDICINE, 2017, 177 (05) : 741 - +
  • [4] GI-Bleeding with Dabigatran, Rivaroxaban and Apixaban
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (08):
  • [5] Dabigatran Compared With Rivaroxaban vs Warfarin Reply
    Parks, Anna L.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2017, 177 (05) : 744 - 744
  • [6] Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
    Efe Eworuke
    Laura Hou
    Rongmei Zhang
    Hui-Lee Wong
    Peter Waldron
    Abby Anderson
    Audrey Gassman
    David Moeny
    Ting-Ying Huang
    Drug Safety, 2021, 44 : 753 - 763
  • [7] Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
    Eworuke, Efe
    Hou, Laura
    Zhang, Rongmei
    Wong, Hui-Lee
    Waldron, Peter
    Anderson, Abby
    Gassman, Audrey
    Moeny, David
    Huang, Ting-Ying
    DRUG SAFETY, 2021, 44 (07) : 753 - 763
  • [8] Thromboembolism, bleeding with dabigatran or warfarin compared
    Reactions Weekly, 2016, 1604 (1) : 12 - 12
  • [9] Management and impact of bleeding events with dabigatran, rivaroxaban, and warfarin
    Yarabinec, Daniel M.
    Hall, Deanne L.
    Coons, James C.
    PHARMACOTHERAPY, 2013, 33 (10): : E268 - E269
  • [10] Less Kidney Damage with Dabigatran and Rivaroxaban compared to Warfarin
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2018, 7 (02) : 104 - 104
12345